European Journal of Cancer
Volume 45, Issue 17 , Pages 3027-3034 , November 2009

Cardiac or cardiopulmonary transplantation in childhood cancer survivors: An increasing need?

  • Gill Levitt

      Affiliations

    • Department of Oncology and Haematology, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK
    • Corresponding Author InformationCorresponding author: Tel.: +44 2074059200; fax: +44 2078138155.
    • ,
  • Antoinette Anazodo

      Affiliations

    • Department of Oncology and Haematology, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK
    • ,
  • Michael Burch

      Affiliations

    • Department of Cardiology, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK
    • ,
  • Kathryn Bunch

      Affiliations

    • Childhood Cancer Research Group, University of Oxford, Richards Building, Old Road Campus, Headington, Oxford OX3 7LG, UK

Received 7 July 2009 ,Accepted 11 August 2009.

References 

  1. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008;100:1368–1379
  2. Oeffinger KC, Mertens AC, Sklar CA, et al. Childhood Cancer Survivors Study Chronic health conditions in adult survivors of childhood cancer. New Engl J Med. 2006;355:1572–1582
  3. Sorensen K, Levitt GA, Bull C, Dorup I, Sullivan ID. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer. 2003;97:1991–1998
  4. Pein F, Levitt G, Bunch K, Rogers CA, Whitehead B. Cardiac transplantation in childhood cancer survivors in Great Britain. Eur J Cancer. 1996;32A:826–830
  5. Stiller C. Childhood cancer in Britain: incidence, survival, mortality. Oxford: Oxford University Press; 2007;
  6. Stiller CA, O’Connor CM, Vincent TJ, Draper GJ. The National Registry of Childhood Tumours and the leukaemia/lymphoma data for 1966–83. In:  Draper GJ editors. The geographical epidemiology of childhood leukaemia and non-Hodgkin lymphomas in Great Britain, 1966–1983, OPCS Studies on Medical and Population Subjects No. 53. London: HMSO; 1991;p. 7–16
  7. SPSS for Windows, Rel. 16.0.2 2008. Chicago: SPSS Inc.
  8. Andrews RE, Fenton MJ, Ridout DA, Burch M British Congenital Cardiac Association. New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and Ireland. Circulation. 2008;117:79–84
  9. Skinner R, Levitt G, Wallace WH. Therapy based LTFU Practice Statement UKCCSG 2005. <www.ukccsg.org.uk/public/followup/PracticeStatement/index.html>, <www.ukccsg.co.uk>.
  10. The Children’s Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Children’s Oncology Group. <http://www.survivorshipguidelines.org/>; 2004.
  11. Pein F, Sakiroglu O, Dahan M, et al. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer. 2004;91:37–44
  12. Armitage JM, Kormos RL, Griffith BP, Fricker FJ, Hardesty RL. Heart transplantation in patients with malignant disease. J Heart Transplant. 1990;9:627–630
  13. Edwards BS, Hunt SA, Fowler MB, et al. Cardiac transplantation in patients with preexisting neoplastic diseases. Am J Cardiol. 1990;65:501–504
  14. Musci M, Loebe M, Grauhan O, et al. Heart transplantation for doxorubicin-induced congestive heart failure in children and adolescents. Transplant Proc. 1997;29:578–579
  15. Grande AM, Rinaldi M, Sinelli S, D’Armini AM, Vigano M. Heart transplantation in chemotherapeutic dilated cardiomyopathy. Transplant Proc. 2003;35:1516–1518
  16. Ward KM, Binns H, Chin C, et al. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare. J Heart Lung Transplant. 2004;23:1040–1045
  17. Dorent R, Pavie A, Nataf P, et al. Heart transplantation is a valid therapeutic option for anthracycline cardiomyopathy. Transplant Proc. 1995;27:1683
  18. Blanco JG, Leisenring WM, Gonzalez-Covarrubias VM, et al. Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and NAD(P)H: quinone oxidoreductase 1 gene NQ01 in Patients who developed anthracycline-related congestive heart failure after childhood cancer. Cancer. 2008;112:2789–2795
  19. Boucek MM, Waltz DA, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric lung and heart/lung transplantation report–2006. J Heart Lung Transplant. 2006;27:978–983
  20. Mangat JS, Rao K, Kingston J, et al. Early pediatric anthracycline cardiotoxicity: managed by serial heart and bone marrow transplantation. J Heart Lung Transplant. 2007;26:658–660
  21. Webber SA, Naftel DC, Fricker FJ, et al. Pediatric Heart Transplant Study Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet. 2006;367:233–239
  22. Esiashvili N, Chiang KY, Hasselle MD, et al. Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol. 2009;90:242–246
  23. Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: part I. Non-endocrine late complications of bone marrow transplantation in childhood: part II. Br J Haematol. 2002;118:3–43
  24. Trofe J, Buell JF, Woodle ES, et al. Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78:972–977

PII: S0959-8049(09)00610-8

doi: 10.1016/j.ejca.2009.08.006

European Journal of Cancer
Volume 45, Issue 17 , Pages 3027-3034 , November 2009

Article Tools

* Image Usage & Resolution